Arbutus Biopharma Corporation ABUS Restructuring Reserve
Restructuring Reserve at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:RestructuringReserveCurrent.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's restructuring reserve.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's restructuring reserve?
- Arbutus Biopharma Corporation (ABUS) reported restructuring reserve of $245K in Q1 2026.
- How has Arbutus Biopharma Corporation's restructuring reserve changed year-over-year?
- Arbutus Biopharma Corporation's restructuring reserve decreased by 95.9% year-over-year, from $5.97M to $245K.
- What does restructuring reserve mean?
- This represents the estimated liability for costs associated with formal restructuring plans, such as severance, facility closures, or asset impairments. It reflects management's commitment to operational efficiency and strategic realignment. These reserves are drawn down as the restructuring activities are executed.